Drugs · Entity Annotation Prototype (beta)

14articles mentioning drugs

19drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: axicabtagene ciloleucel ×

axicabtagene ciloleucel

This drug is selected. Its supporting articles are shown below.

Axicabtagene Ciloleucel14

Articles mentioning axicabtagene ciloleucel

14 articles · page 2 of 2

Classification of patients with relapsed/refractory large B-cell lymphoma who do not develop early CRS/NE toxicity using ZUMA clinical trial data

jitc · abstract · 2025-08-04 · 1 matching annotations

89.2%

axicabtagene ciloleucel prophylactic corticosteroids relapsed/refractory large B-cell lymphoma relapsed and/or refractory large B-cell lymphoma

…data from 390 patients treated with the CD19 CAR T-cell therapy axicabtagene ciloleucel under two prospective clinical trials, ZUMA-1 and ZUMA-7; these…

Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing

jitc · abstract · 2025-07-28 · 1 matching annotations

86.7%

tisagenlecleucel tisa-cel axi-cel axicabtagene ciloleucel

…eater real-world efficacy and cytokine-associated toxicity than tisagenlecleucel (tisa-cel; CD19/4-1BB), for reasons that are poorly understood.…